Upstream Bio (UPB) News Today $18.63 +0.04 (+0.22%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$18.64 +0.01 (+0.05%) As of 10/3/2025 07:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock UPB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Upstream Bio (UPB): Assessing Valuation as Shares Climb 7% Over the Past WeekOctober 4 at 12:36 PM | finance.yahoo.comUpstream Bio, Inc. (NASDAQ:UPB) Receives Consensus Recommendation of "Buy" from BrokeragesOctober 3 at 4:31 PM | marketbeat.comUpstream Bio’s verekitug shows prevention of TSLP binding in respiratory diseaseSeptember 30, 2025 | msn.comUpstream Bio (NASDAQ:UPB) Trading 4.2% Higher - Still a Buy?September 30, 2025 | marketbeat.comUpstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug’s Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European ...September 30, 2025 | finance.yahoo.comUpstream Bio, Inc. Presents Data on Verekitug's Mechanism of Action at ERS Congress, Highlighting Its Potential in Treating TSLP-Driven Severe Respiratory DiseasesSeptember 30, 2025 | quiverquant.comQUpstream Bio Presents Data Showing Structural and Mechanistic Drivers of Verekitug's Potent Pharmacodynamic Activity and Differentiated Clinical Profile at European Respiratory Society CongressSeptember 30, 2025 | globenewswire.comUpstream Bio (NASDAQ:UPB) Shares Down 5.3% - Here's What HappenedSeptember 18, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Trading 5.9% Higher - Still a Buy?September 17, 2025 | marketbeat.comUpstream Bio, Inc. (UPB): A Bull Case TheorySeptember 16, 2025 | msn.comTD Cowen Remains a Buy on Upstream Bio, Inc. (UPB)September 10, 2025 | theglobeandmail.comUpstream Bio Announces Positive Phase 2 Trial ResultsSeptember 9, 2025 | theglobeandmail.comUpstream Bio, Inc. CEO Rand Sutherland to Speak at Stifel 2025 Virtual Immunology and Inflammation ForumSeptember 9, 2025 | quiverquant.comQUpstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation ForumSeptember 9, 2025 | globenewswire.comParkman Healthcare Partners LLC Invests $1.43 Million in Upstream Bio, Inc. $UPBSeptember 8, 2025 | marketbeat.com22,586 Shares in Upstream Bio, Inc. $UPB Bought by Nuveen LLCSeptember 8, 2025 | marketbeat.comUpstream Bio, Inc. - Special CallSeptember 7, 2025 | seekingalpha.comUpstream Bio, Inc. (UPB) Special Call - SlideshowSeptember 5, 2025 | seekingalpha.comADAR1 Capital Management LLC Makes New $92,000 Investment in Upstream Bio, Inc. $UPBSeptember 5, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Sees Large Volume Increase - Time to Buy?September 4, 2025 | marketbeat.comUpstream Bio Shares Rise on Positive Data for Sinus-Disease TreatmentSeptember 3, 2025 | marketwatch.comPositive Buy Rating for Upstream Bio, Inc. Driven by Promising Clinical Trial Results for VerekitugSeptember 2, 2025 | tipranks.comUpstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)September 2, 2025 | globenewswire.comUpstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps ...September 1, 2025 | finance.yahoo.comUpstream Bio, Inc. to Report Top-Line Data from Phase 2 VIBRANT Trial of Verekitug on September 2, 2025September 1, 2025 | quiverquant.comQUpstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)September 1, 2025 | globenewswire.comVelan Capital Investment Management LP Invests $655,000 in Upstream Bio, Inc. $UPBAugust 31, 2025 | marketbeat.comWellington Management Group LLP Decreases Holdings in Upstream Bio, Inc. $UPBAugust 31, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Shares Down 5.4% - What's Next?August 27, 2025 | marketbeat.comPiper Sandler bestätigt 'Overweight'-Rating für Upstream Bio und sieht deutliches KurspotenzialAugust 26, 2025 | de.investing.comUpstream Bio (NASDAQ:UPB) Shares Down 4.8% - Here's What HappenedAugust 20, 2025 | marketbeat.comUpstream Bio Initiates Phase 2 Clinical Trial for COPD Drug, VerekitugAugust 20, 2025 | msn.comUpstream Bio (NASDAQ:UPB) Sees Unusually-High Trading Volume - Here's WhyAugust 12, 2025 | marketbeat.comQ3 EPS Estimates for Upstream Bio Cut by William BlairAugust 9, 2025 | marketbeat.comUpstream Bio Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS LagsAugust 8, 2025 | finance.yahoo.comUpstream Bio (UPB) Q2 R&D Soars 169%August 6, 2025 | fool.comUpstream Bio, Inc. reports Q2 resultsAugust 6, 2025 | seekingalpha.comUpstream Bio Reports Second Quarter 2025 Financial Results and Highlights Continued ProgressAugust 6, 2025 | globenewswire.comUpstream Bio (NASDAQ:UPB) Stock Price Up 8.1% - Still a Buy?July 31, 2025 | marketbeat.comUpstream Bio (UPB) Expected to Announce Quarterly Earnings on TuesdayJuly 29, 2025 | marketbeat.comPromising Outlook for Upstream Bio, Inc. as Verekitug Advances in Inflammatory ConditionsJuly 28, 2025 | tipranks.comPositive Outlook for Upstream Bio, Inc. Driven by Promising Phase II Study of Verekitug in CRSwNP TreatmentJuly 28, 2025 | tipranks.comUpstream Bio Inc. (UPB) Stock Price Today - WSJJuly 25, 2025 | wsj.comUpstream Bio (NASDAQ:UPB) Trading Up 10% - Still a Buy?July 25, 2025 | marketbeat.comUpstream Bio begins phase 2 COPD trial for verekitugJuly 10, 2025 | uk.investing.comUpstream Bio Initiates Phase 2 VENTURE Trial for Verekitug in Moderate-to-Severe COPD, Expanding Its Respiratory PortfolioJuly 8, 2025 | quiverquant.comQUpstream Bio Announces First Patient Dosed in Phase 2 Clinical Trial of Verekitug in Chronic Obstructive Pulmonary Disease (COPD)July 8, 2025 | globenewswire.comUPB Upstream Bio, Inc. - Seeking AlphaJune 28, 2025 | seekingalpha.comUpstream Bio (NASDAQ:UPB) Trading 7.8% Higher - Should You Buy?June 20, 2025 | marketbeat.comUpstream Bio (NASDAQ:UPB) Shares Gap Down - What's Next?June 18, 2025 | marketbeat.com Get Upstream Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for UPB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. UPB Media Mentions By Week UPB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UPB News Sentiment▼0.510.54▲Average Medical News Sentiment UPB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UPB Articles This Week▼72▲UPB Articles Average Week Get the Latest News and Ratings for UPB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Upstream Bio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CRNX News ZLAB News MIRM News AKRO News AAPG News SRRK News ACAD News ADMA News LNTH News MENS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:UPB) was last updated on 10/5/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Upstream Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Upstream Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
